Abstract
Objectives
Tuberculosis is an infectious airborne disease caused by Mycobacterium tuberculosis. Pulmonary tuberculosis is the ninth most frequent complication of diabetes mellitus. The co-existence of TB and DM in patient causes severe TB symptoms, modify radiological findings, slower response to treatment outcomes and prognosis. IFN-γ is the key cytokine which play role in the protective immune response against mycobacterium infection. The main function of IFN-γ is macrophage activation which is able to exert its microbicidal functions. Estimation and comparison of pre and post treatment serum IFN-γ among pulmonary tuberculosis among diabetic and non-diabetic patients.
Methods
The study was conducted in the Departments of Biochemistry and Pulmonary Medicine, FMHS, SGT University, Budhera, Gurugram and District TB Centre, Gurugram, Haryana, India. In this study, 100 newly diagnosed PTB patients without diabetes mellitus and 100 newly diagnosed PTB patients with diabetes mellitus (PTB-DM) above 15 years of age were included after obtaining written consent. 5 mL venous blood was collected from patients of pre and post anti-tubercular treatment. The level of IFN-γ was measured by ELISA method.
Results
The circulating level of IFN-γ in PTB patients was significantly decreased in post-treatment (25.53 ± 6.12 pg/mL) compared to pre-treatment (58.76 ± 16.02 pg/mL) with t-value 32.03 and p-value <0.001. The circulating level of IFN-γ in PTB-DM patients was significantly decreased in post treatment (29.11 ± 7.41 pg/mL) compared to pre-treatment (44.14 ± 10.85 pg/mL) with t-value 31.35 and p-value <0.001. In the present study, level of IFN-γ in pre-treatment PTB patients (58.76 ± 16.02 pg/mL) was significantly raised compared to PTB-DM patients (44.14 ± 10.85 pg/mL) with t-value 7.55 and p-value <0.001. However, level of IFN-γ in post-treatment PTB patients (25.53 ± 6.12 pg/mL) was significantly low compared to PTB-DM patients (29.11 ± 7.41 pg/mL) with t-value 3.71 and p-value <0.001.
Conclusions
The decreased level of IFN-γ in post-treatment compared to pre-treatment in both PTB and PTB-DM patients had shown efficacy of anti-tubercular treatment. However, the post treatment level of IFN-γ was high in PTB-DM patients compared to PTB patients which verified that effect of ATT was low in PTB-DM.
Acknowledgment
We sincerely thank all the faculty members and non-teaching staffs of Departments of Biochemistry and Pulmonary Medicine, FMHS, SGT University, and District TB Officer, Medical Officers, counselors of DOTS centre, all TB health worker and laboratory technician of District TB Centre, Gurugram. The Special thanks to Mr. Sunil Kumar Chamola, Statistician, Department of Preventive & Social Medicine, FMHS, SGT University, Gurugram for his contribution in statistical analysis of this study. We are also thankful to all Laboratory technicians of Central Biochemistry Laboratory and all the nursing staffs of OPD and IPD of Pulmonary Medicine and, SGT University. Finally yet importantly, we thank all our patients without whom this study would never have been possible.
-
Research funding: None declared
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Conflict of interest: None declared.
References
1. Kasper, DL, Fauci, AS, Hauser, SL, Jameson, JL, Longo, DL, Loscalzo, J, et al.. Harrison’s principles of internal medicine, 19th ed. New York, USA: McGraw Hill Education; 2015:1102–3 pp.Search in Google Scholar
2. World Health Organization. Global tuberculosis report 2015. Geneva, Switzerland: WHO; 2015.Search in Google Scholar
3. Moghaddam, HT, Moghaddam, ZE, Khademi, G, Bahreini, A, Saeidi, M. Tuberculosis: past, present and future. Int J Pediatr 2016;4:1243–54.Search in Google Scholar
4. Caufield, AJ, Wengenack, NL. Diagnosis of active tuberculosis disease: from microscopy to molecular technique. J Clin Tuber Other Mycobac dis 2016;4:33–43.10.1016/j.jctube.2016.05.005Search in Google Scholar PubMed PubMed Central
5. Sidibe, EH. Main complications of diabetes mellitus in Africa. Ann Med Interne 2000;151:624–8.Search in Google Scholar
6. Satyavani, K, Vijay, V. Diabetes and tuberculosis- a co-epidemic of public health importance in the developing world. Current Sci 2017;113:1296–302. https://doi.org/10.18520/cs/v113/i07/1296-1302.Search in Google Scholar
7. Schreiber, RD, Farrar, MA. The biology and biochemistry of interferon-gamma and its receptor. Gastroenterol Jpn 1993;28:88–94. https://doi.org/10.1007/bf02782897.Search in Google Scholar
8. Lin, CF, Young, HA. The talented interferon-gamma. Adv Biosci Biotechnol 2013;4:6–13. https://doi.org/10.4236/abb.2013.47a3002.Search in Google Scholar
9. Cooper, AM, Khader, SA. The role of cytokines in the initiation, expansion and control of cellular immunity to tuberculosis. Immunol Rev 2008;226:191–204. https://doi.org/10.1111/j.1600-065x.2008.00702.x.Search in Google Scholar PubMed PubMed Central
10. Flesch, IEA, Hess, JH, Huang, S, Aguet, M, Rothe, J, Bluethmann, H, et al.. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor-α. J Exp Med 1995;181:1615–21, https://doi.org/10.1084/jem.181.5.1615.Search in Google Scholar PubMed PubMed Central
11. Fenton, MJ, Vermeulen, MW, Kim, S, Burdick, M, Strieter, RM, Kornfeld, H, et al.. Induction of γ interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 1997;65:5149–56. https://doi.org/10.1128/iai.65.12.5149-5156.1997.Search in Google Scholar PubMed PubMed Central
12. Oberholzer, A, Oberholzer, C, Moldawer, LL. Cytokine signaling—regulation of the immune response in normal and critically ill states. Crit Care Med 2000;28:N3-12. https://doi.org/10.1097/00003246-200004001-00002.Search in Google Scholar PubMed
13. Fiske, CT, Shintani, AK, de Almeida, AS, Kalams, SA, Sterling, TR. Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis. Clin Vaccine Immunol 2012;19:1142–9. https://doi.org/10.1128/cvi.00221-12.Search in Google Scholar PubMed PubMed Central
14. Ashenafi, S, Aderaye, G, Bekele, A, Zewdie, M, Aseffa, G, Hoang, ATN, et al.. Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3. Clin Immunol 2014;151:84–99. https://doi.org/10.1016/j.clim.2014.01.010.Search in Google Scholar PubMed
15. Clifford, V, Zufferey, C, He, Y, Connell, T, Curtis, N. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review. Tuberculosis 2015;95:639–50. https://doi.org/10.1016/j.tube.2015.07.002.Search in Google Scholar PubMed
16. El-Sabbagh, AM, El-Kazzaz, SS, Mashaly, GE, Alkhiary, W, Sheta, TF. Interferone-gamma (INF-γ) and interleukin-2 (IL-2) as immunological markers in pulmonary tuberculosis. J Clin Immunol Immunopathol Res 2016;7:1–6.Search in Google Scholar
17. Liang, L, Shi, R, Liu, X, Yuan, X, Zheng, S, Zhang, G, et al.. Interferon gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis. Int J Tubercul Lung Dis 2017;21:1145–9. https://doi.org/10.5588/ijtld.16.0880.Search in Google Scholar PubMed PubMed Central
18. Tambunan, BA, Priyanto, H, Nugraha, J, Soedarsono, S. CD4+ AND CD8+ T-cells expressing interferon gamma in active pulmonary tuberculosis patients. Afr J Infect Dis 2018;12:49–53. https://doi.org/10.21010/ajid.v12i1s.6.Search in Google Scholar
19. Sauzullo, I, Mengoni, F, Lichtner, M, Massetti, AP, Rossi, R, Lannetta, M, et al.. In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T-cell response. PLoS One 2009;4:e5187. https://doi.org/10.1371/journal.pone.0005187.Search in Google Scholar PubMed PubMed Central
20. Ribeiro, S, Dooley, K, Hackman, J, Loredo, C, Efron, A, Chaisson, RE, et al.. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis 2009;9:23. https://doi.org/10.1186/1471-2334-9-23.Search in Google Scholar PubMed PubMed Central
21. Lee, SW, Lee, CT, Yim, JJ. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis 2010;10:300. https://doi.org/10.1186/1471-2334-10-300.Search in Google Scholar PubMed PubMed Central
22. Hussain, S, Afzal, N, Javaid, K, Ullah, MI, Ahmad, T, Zaman, SU. Level of interferon gamma in the blood of tuberculosis patients. Iran J Immunol 2010;7:1–7.Search in Google Scholar
23. Moulaei, NA, Niazi, AA, Saeidpour-Parizi, A, Shahba, S. Role of interferone gamma in bronchoalveolar lavage fluid on distinguishing active pulmonary tuberculosis from other pulmonary diseases. ZJRMS 2014;16:5–8.Search in Google Scholar
24. Shaviya, N, Budambula, V, Webale, MK, Were, T. Circulating interferone gamma levels are associated with low body weight in newly diagnosed Kenya non substance using tuberculosis individuals. In: Interdisciplinary perspectives on infectious diaseases. Hindawi Publishing Corporation; 2016:1–9 pp.10.1155/2016/9415364Search in Google Scholar PubMed PubMed Central
© 2022 Walter de Gruyter GmbH, Berlin/Boston
